Anti-RSV G antibodies (AIMM Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-RSV G antibodies (AIMM Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionRespiratory syncytial virus G protein inhibitors
TargetsRespiratory syncytial virus G protein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAimm Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAimm Therapeutics
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A